We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Drug Discovery

Drug Discovery

Stay up to date on the topics that matter to you

A picture of Joanna Owens, PhD

Joanna Owens, PhD profile page

Director of Faraday Science Communications

Joanna brings more than 20 years’ experience writing about a wide range of scientific topics in biosciences, pharmaceuticals and biotechnology. After a PhD in Molecular Toxicology, Joanna began a career in science publishing, as associate editor on Drug Discovery Today and later as senior editor, Nature Reviews Drug Discovery. In 2007, she joined one of the world’s largest biomedical charities, Cancer Research UK, specializing in plain language science communications for patients and the public. Joanna has been a freelance writer since 2017, covering all biomedical topics with a focus on oncology, pharmacology and drug discovery.

Got a Question for Joanna Owens, PhD?

Get in touch using the contact form linked here and we’ll get back to you shortly

Published Content

Total: 52

The Global Push for a COVID-19 Vaccine content piece image

The Global Push for a COVID-19 Vaccine

Worldwide, researchers are racing to develop a vaccine against SARS-CoV-2, the virus that causes COVID-19. Many different parties within the scientific community are working to develop a vaccine – from scientists who have dedicated their careers to the study of coronaviruses, to specialists in vaccine design from both academia and industry, to those in other disciplines who have redirected their efforts to combat this global health threat. In this article, we meet some of the teams who are at the forefront of this endeavor.

Six Steps Towards Understanding the Microbiome and Cancer content piece image

Six Steps Towards Understanding the Microbiome and Cancer

In cancer, rapidly emerging evidence suggests that the microbiome influences disease progression in a myriad of direct and indirect ways. In this listicle, we look at recent research developments directed towards exploring the emerging “oncomicrobiome”.

Diverse Applications of High-Content and High-Throughput Screening content piece image

Diverse Applications of High-Content and High-Throughput Screening

In this article, we use COVID-19 and cancer to illustrate the range of screening tools at our fingertips today.

Targeting the Tumor Microenvironment content piece image

Targeting the Tumor Microenvironment

In this article, we learn why it’s not just the tumor itself that needs to be targeted and hear about research that aims to exploit the tumor microenvironment.

Advances in High-Throughput Screening content piece image

Advances in High-Throughput Screening

Ever since the advent of the multi-well plate, researchers have been pioneering new ways to miniaturize assays for high-throughput screening (HTS). Here, we share two examples that illustrate the power of modern HTS in drug discovery.

Advances in Cancer Drug Discovery content piece image

Advances in Cancer Drug Discovery

From optimizing immunotherapy to second-guessing cancer’s next evolutionary step – there has never been a more innovative era in cancer drug discovery.

Phenotypic Screening – Advances in Technologies and Techniques content piece image

Phenotypic Screening – Advances in Technologies and Techniques

Phenotypic screening is gaining new momentum in drug discovery with the hope that this approach will improve the success rate of drug approval. In this article we look at some of the latest screening tools and their applications.

The Immune System and Cancer content piece image

The Immune System and Cancer

There has been an acceleration in our understanding of how cancer evades the immune system, and an explosion in new therapeutics that re-configure the immune system to mount a powerful anticancer response. Download this list to learn more.

Optimizing Kinetics in Drug Discovery content piece image

Optimizing Kinetics in Drug Discovery

As biology presents ever-more challenging targets, the chemistry world is pushing ahead with new tools to design or discover drugs that have optimal kinetics. We look at two different approaches being used to explore and optimize the kinetics of tomorrow’s medicines.

The Evolving Field of Cancer Biomarkers content piece image

The Evolving Field of Cancer Biomarkers

Given the complexity of cancer, it’s arguably unlikely that single molecules will work as clinically meaningful biomarkers for cancer. Today, biomarker discovery involves detecting patterns – characteristics or phenotypes that can be measured and monitored throughout a patient’s journey. Here, we look at two approaches being explored in this evolving field.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter